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Background: Data on late presentation (LP) in Poland are not available from
surveillance authorities, while to date it is the most effective measure of HIV
testing access and linkage to care. To address this gap clinical centres initiated
TAK Polska project to assess the prevalence and characteristics of AIDS and LP
in the country.
Methods: Clinical and demographic data were collected retrospectively on
predefined questionnaires for all patients newly registered in 13 HIV centres in
2016 and 2017. Data were cleaned and queried centrally. LP was defined as
AIDS and/or CD4 count<350 cells/mm3 at first visit. Information on number of
HIV tests performed in 2016 in voluntary counselling and testing centres
(VCTs) in the region represented by each clinical centre were acquired from
national VCTs system. In statistical analyses logistic regression models were
used to identify factors associated with AIDS and LP.
Results: Data on 1751 patients were received (89.6% men, 64% infected
through MSM contacts). The median age was 33.1 (IQR: 27.5–39.8) years, CD4
count 383 (210–552) cells/mm3. Information about AIDS at baseline was
available for 1535 (87.7%) of patients: 693 (45.1%) patients were LP and 184
(11.7%) presented with AIDS. The prevalence of AIDS was highest in cities
from regions with lowest number of HIV tests in VCTs (Figure).
The relation between HIV test coverage and AIDS at diagnosis in Poland
stratified by cities
The most common AIDS conditions: pneumocystis pneumonia (25.2%),
candidiasis (22.4%), tuberculosis (14.7%) and wasting syndrome (14.0%).
The odds of AIDS/LP were higher for each 10 years older (aOR 1.65[1.41–1.92]
/ 1.15 [0.7–1.74]), persons infected through heterosexual contacts (2.07 [1.31–
3.22] / 2.18 [1.00–4.94]) and injecting drug use (4.11 [1.29–7.88] / 3.13 [1.29–
7.88]).
Conclusions: LP/AIDS at first clinical visit is still common in Poland with large
variation between the centres. This indicates suboptimal testing for HIV in
certain regions of the country and for some groups, especially injecting drug
users.
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Purpose: Describe the HIV-infected patients lost to follow-up (LTFU) at our
Centre and identify variables that might predict a subsequent re-linkage to
care (RLTC).
Method: We conducted a single center, retrospective study including patients
followed at the Infectious Diseases Clinic of San Martino Policlinic Hospital,
Genoa. LTFU was defined as missing appointments for both visits and exams
for≥12 months. All patients LTFU during the year 2015, who were already in
care at the beginning of the previous year, were included. All RLTC up to
December 2018 were registered. Data were retrieved through medical records
and the electronic MedInfo database. The possible association of different
variables with RLTC was assessed through univariable logistic regression
model.
Results: Sixty-three patients were enrolled, of whom 32 (50.8%) re-entered
care. Median time between LTFU and RLTC was 1 year (range 1–3 years).
Median viral load at RLTC was 46.5 copies/mL (IQR 0–1500 copies/mL).
Seventeen patients (53.1%) had undetectable viral load (HIV RNA<50 copies/
mL) at RLTC. Other characteristics of the two populations are illustrated in
table 1. At univariable logistic regression, only age showed a statistically
significant association with RLTC (OR 0.9; 95% CI 0.9–1.0; p=0.033). No
multivariable analysis was performed due to the small sample size.
Conclusion: To maintain linkage to care is crucial in the cascade of care of
HIV-infected patients.
Half of the patients we LTFU in 2015 re-entered care after a median time of
1 year; half of them had an undetectable viral load upon re-linkage, testifying
that they carried on antiretroviral treatment despite the apparent LTFU.
Younger age was the only factor we found could predict the re-entrance in
care.
Limitations to the interpretability of our data stem from the small sample size
and the retrospective design of the study, with a consistent amount of missing
data.
Table 1. Characteristics of LTFU and RLTC populations with unadjusted odds
ratio and corresponding 95% confidence intervals.












Median Age 53 years (IQR 45–60) 49 years (range 43–
58)
0.9 (0.9–1.0) 0.033


















CDC stage A 26 (45.6) B 16
(28.1) C 15 (26.3)
Missing 6
A 17 (56.7) B 6








Yes 11 (21.2) No 41
(78.8) Missing 11








Yes 7 (13.2) No 46
(86.8) Missing 10








12 years (IQR 6–22) 12 years (IQR 8–23) 1.0 (1.0–1.1) 0.565
Median nadir of
CD4+
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Purpose: To control the growing HIV epidemic in Indonesia, the Strategic Use
of Antiretroviral (SUFA) was launched in 2013. Since an evaluation of SUFA’s
impact on the rate HIV testing and detection has not been performed, we
performed a study to assess the impact on these outcomes.
Method: Monthly data were collected from persons 15 years of age or older
from 13 cities. The pre-SUFA data collection period was defined as 26 Dec
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